Blacksmith Medicines Announces $3.3M in Funding from NIAID to Support Clinical Trial Manufacturing of Novel Antibioticblacksmithmed2024-02-20T10:03:06-08:0002.21.2024|
Blacksmith Medicines and Zoetis Announce Research Collaboration for Novel Animal Health Antibioticsblacksmithmed2024-02-13T09:36:54-08:0002.14.2024|
Blacksmith Medicines announces oncology scientific advisorsblacksmithmed2023-01-05T06:02:55-08:0001.05.2023|
Blacksmith Medicines announces merger with Forge Therapeutics to create leading company developing medicines targeting metalloenzymesblacksmithmed2023-01-04T12:39:59-08:0001.02.2023|
Blacksmith Medicines launches with seed funding and a research collaboration with Lillyblacksmithmed2023-01-04T13:08:03-08:0001.08.2021|
